These results suggest that in vivo injection of ASO-Ttbk1 successfully suppressed p-tau formation at multiple sites relevant to AD pathology in the hippocampus in PS19 mice, validating its inhibitory effect on the pre-tangle formation in early-stage AD. The gene discussed is TTBK1; the disease is Alzheimer disease.